Orap Alternatives Compared
Orap | Clonidine | Guanfacine |
|
---|
Orap (pimozide) | Clonidine | Guanfacine |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Tourette's Syndrome. Orap may also be used for purposes not listed in this medication guide. |
Prescription only
Clonidine can be used to lower blood pressure and treat ADHD; however, it causes sedation, and tolerance can develop to its blood pressure lowering effects. Clonidine should not be stopped suddenly... View more |
Prescription only
Guanfacine is used to treat high blood pressure and the extended-release form (brand name Intuniv) is approved for the treatment of ADHD. Guanfacine can cause sedation, especially on therapy... View more |
Related suggestions Tourette's Syndrome
|
|||||||||||||||
More about Orap (pimozide) | More about Clonidine | More about Guanfacine | ||||||||||||||||
Generic Status | ||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Orap has an average rating of 7.1 out of 10 from a total of 17 ratings on Drugs.com. 60% of reviewers reported a positive effect, while 13% reported a negative effect. |
Clonidine has an average rating of 7.1 out of 10 from a total of 731 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 22% reported a negative effect. |
Guanfacine has an average rating of 5.9 out of 10 from a total of 304 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 36% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
Common side effects include:
See also: Orap side effects in more detail. |
Commonly reported side effects include:
See also: clonidine side effects in more detail. |
Commonly reported side effects include:
See also: guanfacine side effects in more detail. |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all clonidine prices |
View all guanfacine prices |
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
Catapres, Catapres-TTS, Clonidine ER, Duraclon, Kapvay, Nexiclon XR | Intuniv | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
50 hours |
15 hours |
18 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 622 drugs are known to interact with Orap:
|
A total of 366 drugs are known to interact with clonidine:
|
A total of 449 drugs are known to interact with guanfacine:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
Disease Interactions | ||||||||||||||||||
|
||||||||||||||||||
First Approval Date | ||||||||||||||||||
July 31, 1984 |
September 03, 1974 |
October 27, 1986 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
|||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.